פורי-נתול טבליות 50 מג ישראל - עברית - Ministry of Health

פורי-נתול טבליות 50 מג

padagis israel agencies ltd, israel - mercaptopurine - טבליה - mercaptopurine 50 mg - mercaptopurine - mercaptopurine - for the treatment of acute leukemia and also in cases of chronic myelogenous leukemia.

Urine collection device ישראל - עברית - Ministry of Health

urine collection device

e.z.l packaging ltd - כלל האוכלוסיה - כלי לאיסוף שתן

URINE CUP ישראל - עברית - Ministry of Health

urine cup

אגית טכנולוגיות (האגודה לבריאות הציבור - כלל האוכלוסיה - לשימוש כללי בבית חולים ומרפאות ללקיחת שתן

urine bags ישראל - עברית - Ministry of Health

urine bags

אסתר טכנולוגיות בע"מ - אחות - שקיות שתן

Urine Bags ישראל - עברית - Ministry of Health

urine bags

י.גיל מדיקל בע"מ - רופא

קסטרל 2.5 מ"ג ישראל - עברית - Ministry of Health

קסטרל 2.5 מ"ג

sanofi - aventis israel ltd - alfuzosin hydrochloride 2.5 mg - tablets - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy, notably when surgery has to be delayed for whaterver reason and during episodes of severe symptoms of adenoma, especially in elderly patients.

קפרלסה 100 מ"ג ישראל - עברית - Ministry of Health

קפרלסה 100 מ"ג

astra zeneca israel ltd - vandetanib 100 mg - film coated tablets - vandetanib - caprelsa is indicated for the treatment of aggressive and symptomatic medullary thyroid cancer (mtc) in patients with unresectable locally advanced or metastatic disease. for patients in whom rearranged during transfection (ret) mutation is not known or is negative, a possible lower benefit should be taken into account before individual treatment decision

קפרלסה 300 מ"ג ישראל - עברית - Ministry of Health

קפרלסה 300 מ"ג

astra zeneca israel ltd - vandetanib 300 mg - film coated tablets - vandetanib - caprelsa is indicated for the treatment of aggressive and symptomatic medullary thyroid cancer (mtc) in patients with unresectable locally advanced or metastatic disease. for patients in whom rearranged during transfection (ret) mutation is not known or is negative, a possible lower benefit should be taken into account before individual treatment decision

ריספרדל 1 מ"ג ישראל - עברית - Ministry of Health

ריספרדל 1 מ"ג

j-c health care ltd - risperidone 1 mg - film coated tablets - risperidone - risperdal is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperdal was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperdal is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperdal is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperdal is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distractibility or

ריספפר 1 מ"ג ישראל - עברית - Ministry of Health

ריספפר 1 מ"ג

pharmalogic ltd - risperidone 1 mg - film coated tablets - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract